Business Description
Oncoclinicas Do Brasil Servicos Medicos SA
ISIN : BRONCOACNOR6
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 1.98 | |||||
Debt-to-EBITDA | 4.07 | |||||
Interest Coverage | 1.32 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.38 | |||||
Beneish M-Score | -2.05 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.5 | |||||
3-Year EBITDA Growth Rate | 78.3 | |||||
3-Year FCF Growth Rate | -141.7 | |||||
3-Year Book Growth Rate | 65.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 12.16 | |||||
9-Day RSI | 20.78 | |||||
14-Day RSI | 25.22 | |||||
6-1 Month Momentum % | 5.61 | |||||
12-1 Month Momentum % | 15.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.71 | |||||
Quick Ratio | 1.6 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 16.05 | |||||
Days Sales Outstanding | 54.19 | |||||
Days Payable | 70.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.2 | |||||
Shareholder Yield % | -36.29 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 35.14 | |||||
Operating Margin % | 13.43 | |||||
Net Margin % | 4.07 | |||||
FCF Margin % | -6.62 | |||||
ROE % | 10.27 | |||||
ROA % | 2.61 | |||||
ROIC % | 11.28 | |||||
ROC (Joel Greenblatt) % | 72.81 | |||||
ROCE % | 12.7 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 16.08 | |||||
PE Ratio without NRI | 28.81 | |||||
PEG Ratio | 0.58 | |||||
PS Ratio | 0.65 | |||||
PB Ratio | 1.5 | |||||
EV-to-EBIT | 8.39 | |||||
EV-to-Forward-EBIT | 11.2 | |||||
EV-to-EBITDA | 6.46 | |||||
EV-to-Forward-EBITDA | 8.83 | |||||
EV-to-Revenue | 1.32 | |||||
EV-to-Forward-Revenue | 1.47 | |||||
EV-to-FCF | -19.92 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.93 | |||||
Earnings Yield (Greenblatt) % | 11.92 | |||||
FCF Yield % | -10.56 |